On this week’s Tech Nation, James Vincent about his book, “Beyond Measure: The Hidden History of Measurement from Cubits to Quantum Constants”, and our age-old propensity as humans … to measure things. Then Dr. Rob Ross from Surface Oncology tells us why the first generation of immuno-oncology drugs only worked on 15% of cancer patients, and how Surface Oncology is tackling the other 85%. Their Phase 2 trials in lung cancer and liver cancer are recruiting now.
Fler avsnitt av TechNation Radio Podcast
Visa alla avsnitt av TechNation Radio PodcastTechNation Radio Podcast med Tech Nation finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
